2D-QSAR, In Silico Molecular Docking, ADMET Studies of Synthesized Benzimidazole Derivatives as Inhibitors against EGFR Kinase Domain Complexed with TAK-285

Dipak P. Kardile; Vishwas C. Bhagat; Pravin B. Awate; Vishal S. Adak; Tushar B. Shinde; Avinash V. Dhobale; Adinath C. Bhusari

doi:10.52711/0974-360X.2026.00542

Research Journal of Pharmacy and Technology

ISSN

0974-360X (Online)
0974-3618 (Print)

Submit Article

2D-QSAR, In Silico Molecular Docking, ADMET Studies of Synthesized Benzimidazole Derivatives as Inhibitors against EGFR Kinase Domain Complexed with TAK-285

Author(s): Dipak P. Kardile, Vishwas C. Bhagat, Pravin B. Awate, Vishal S. Adak, Tushar B. Shinde, Avinash V. Dhobale, Adinath C. Bhusari

Email(s): kardiledeepak@gmail.com

DOI: 10.52711/0974-360X.2026.00542

Address: Dipak P. Kardile, Vishwas C. Bhagat, Pravin B. Awate, Vishal S. Adak, Tushar B. Shinde, Avinash V. Dhobale, Adinath C. Bhusari
Rajgad Dnyanpeeth’s College of Pharmacy, Bhor, Pune, Maharashtra, India - 412 206.
*Corresponding Author

Published In: Volume - 19, Issue - 8, Year - 2026

Keywords:

Cite this article:
Dipak P. Kardile, Vishwas C. Bhagat, Pravin B. Awate, Vishal S. Adak, Tushar B. Shinde, Avinash V. Dhobale, Adinath C. Bhusari. 2D-QSAR, In Silico Molecular Docking, ADMET Studies of Synthesized Benzimidazole Derivatives as Inhibitors against EGFR Kinase Domain Complexed with TAK-285. Research Journal of Pharmacy and Technology. 2026;19(8):3848-4. doi: 10.52711/0974-360X.2026.00542

Purchase PDF